Jai Hyun Kwon
Venture Partner @ GT Healthcare Capital Partners
Jai Hyun Kwon is a startup investor at GT Healthcare Capital Partners. Dr. Kwon serves as Venture Partner at GT Healthcare Capital Partners. Most recently, Dr. Kwon served as Director, Head of Corporate Development and Transactions at Genexine, a Korean clinical stage biotechnology company focused on the development and commercialization of innovative immunotherapeutics and next generation novel long-actingbiologics. Before joining Genexine, Dr. Kown was Vice President, Chief Strategy Officer at TheragenEtex, a genomics company developing innovative diagnosis tools and new drugs using the genomics and bioinformatics technologies. Before joining TheragenEtex, Dr. Kwon was a research analyst at Daewoo Security, covering the biotechnology and pharmaceutical sector. Dr. Kwon started in industry as Manager, Business Development at Oscotec, a bone specialized biotechnology company in Korea.Dr. Kwon received his Doctor of Philosophy degree in Biopharmaceutical Engineering, Master of Science in Life Science, Bachelor of Science in Genetic Engineering, all from Korea University in Seoul, Korea.
Last updated:
For AI agents: llms.txt
About GT Healthcare Capital Partners
GT Healthcare Capital Partners (“GT Healthcare”) is an Asia-based private investment partnership that specializes in healthcare investments around the globe that aim to change technology landscapes. GT Healthcare intends to provide capital and scale expertise to healthcare businesses in Asia / Greater China.
GT Healthcare Capital Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Alan Au
Founder / Managing Partner
|
|||
|
Jai Hyun Kwon
Venture Partner
|
|||
|
Jason Yeung
Partner
|
|||
Mingxi Li
Partner
|
|||
1 more contact available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
